The Combination of Aroxybutynin and Atomoxetine in the Treatment of Obstructive Sleep Apnea (MARIPOSA): A Randomized Controlled Trial-Reference-Cited by-同舟云学术

The Combination of Aroxybutynin and Atomoxetine in the Treatment of Obstructive Sleep Apnea (MARIPOSA): A Randomized Controlled Trial

Published:2023-12-15 Issue:12 Volume:208 Page:1316-1327
ISSN:1073-449X
Container-title:American Journal of Respiratory and Critical Care Medicine
language:en
Short-container-title:Am J Respir Crit Care Med

Author:

Schweitzer Paula K.¹,Taranto-Montemurro Luigi²,Ojile Joseph M.³,Thein Stephen G.⁴,Drake Christopher L.⁵,Rosenberg Russell⁶,Corser Bruce⁷,Abaluck Brian⁸,Sangal R. Bart⁹¹⁰,Maynard James¹¹

Affiliation:

1. Sleep Medicine and Research Center, St. Luke’s Hospital, Chesterfield, Missouri;

2. Apnimed Inc., Cambridge, Massachusetts;

3. Clayton Sleep Institute, St. Louis, Missouri;

4. Pacific Research Network, an Evolution Research Group Portfolio Site, San Diego, California;

5. Thomas Roth Sleep Disorders and Research Center, Henry Ford Health System, Detroit, Michigan;

6. NeuroTrials Research Inc., Atlanta, Georgia;

7. Intrepid Research, Cincinnati, Ohio;

8. Sleep Medicine, Brian Abaluck, M.D., Malvern, Pennsylvania;

9. Sleep & Attention Disorders Institute, Sterling Heights, Michigan;

10. Oakland University William Beaumont School of Medicine, Rochester, Michigan; and

11. CTI Clinical Research Center, Cincinnati, Ohio

Funder

Apnimed Inc

Publisher

American Thoracic Society

Subject

Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine

Link

https://www.atsjournals.org/doi/pdf/10.1164/rccm.202306-1036OC

Reference33 articles.

1. Estimation of the global prevalence and burden of obstructive sleep apnoea: a literature-based analysis

2. Prevalence of sleep-disordered breathing in the general population: the HypnoLaus study

3. Sleep Apnea

4. The Impact of Obstructive Sleep Apnea on Metabolic and Inflammatory Markers in Consecutive Patients with Metabolic Syndrome

5. The Effect of CPAP in Normalizing Daytime Sleepiness, Quality of Life, and Neurocognitive Function in Patients with Moderate to Severe OSA

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Obstructive sleep apnea and obesity: A review of epidemiology, pathophysiology and the effect of weight-loss treatments;Sleep Medicine Reviews;2024-12

2. Nasal turbinate lymphatic obstruction: a proposed new paradigm in the etiology of essential hypertension;Frontiers in Medicine;2024-08-16

3. Gender medicine and sleep disorders: from basic science to clinical research;Frontiers in Neurology;2024-07-10

4. Obstructive sleep apnea hypopnea syndrome and vascular lesions: An update on what we currently know;Sleep Medicine;2024-07

5. Tackling obstructive sleep apnea with pharmacotherapeutics: expert guidance;Expert Opinion on Pharmacotherapy;2024-05-23